Conserved HBV and HCV sequences useful for gene silencing
US9982263B2 · kind B2 · utility
6Cited by
26References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 2015 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | Oct 23, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Conserved consensus sequences from known hepatitis B virus strains and known hepatitis C virus strains, which are useful in inhibiting the expression of the viruses in mammalian cells, are provided. These sequences are useful to silence the genes of HBV and HCV, thereby providing therapeutic utility against HBV and HCV viral infection in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.